文献速递呼吸衰竭与机械通气心脑血管急症

D-二聚体/纤维蛋白原比值能否用于排除静脉血栓栓塞症?

Could a D-dimer/fibrinogen ratio have a role in ruling-out venous thromboembolism?
PubMed 文献 · Emerg Med J · 2021-09-07
一句话结论回顾性研究显示D-二聚体/纤维蛋白原比值(DFR)切点2.65排除VTE的敏感性与D-二聚体500 ng/mL相当,特异性更高,但仅为探索性结果,尚不能常规使用。

该研究为意大利San Raffaele医院急诊科2017年的回顾性病历审查,纳入疑似肺栓塞92例和疑似深静脉血栓154例,共67例(27%)确诊VTE。研究比较DFR与D-二聚体500 ng/mL、1000 ng/mL切点的诊断性能,DFR最佳切点为2.65。在全样本和低危患者中,DFR 2.65的敏感性与D-二聚体500 ng/mL相同(97%,95%CI 89.8%-99.2%),特异性更高(55.3% vs 22.9%)。作者结论为DFR可能提高高危VTE急诊人群的特异性,但属探索性信息,需前瞻性多中心研究验证后方可考虑常规使用。

要点

  • 在疑似VTE急诊患者中,DFR切点2.65的敏感性为97%(95%CI 89.8%-99.2%),与D-二聚体500 ng/mL切点相同。
  • DFR 2.65在全样本中特异性为55.3%(95%CI 48.0%-62.4%),高于D-二聚体500 ng/mL(22.9%)和1000 ng/mL(45.8%)。
  • D-二聚体1000 ng/mL切点敏感性略低(95.5%,95%CI 87.6%-98.5%)。
  • 该研究为单中心回顾性病历审查,DFR 2.65仅为探索性切点,作者明确需前瞻性多中心研究验证后才能考虑常规使用。
  • 研究同时纳入高危和低危预检概率患者,低危患者进一步分层为DVT或PE低风险。

适用人群与场景

  • 在意大利San Raffaele医院急诊科接受胸部CT血管造影或静脉超声检查的疑似VTE患者,包括疑似肺栓塞92例和疑似深静脉血栓154例。
  • 研究纳入高危和低危预检概率患者,低概率患者进一步分层为深静脉血栓或肺栓塞低风险。

诊断标准与关键阈值

  • 使用回顾性计算的Wells评分识别高危和低危预检概率患者。
  • DFR最佳切点为2.65。
  • 对照D-二聚体切点为500 ng/mL和1000 ng/mL。

处置流程与药物剂量

  • 原文未提及

红旗征与不能漏的情况

  • 原文未提及

研究设计与关键结果

  • DFR最佳切点2.65在全样本和低危患者中敏感性为97%(95%CI 89.8%-99.2%),与D-二聚体500 ng/mL切点相同;D-二聚体1000 ng/mL切点敏感性为95.5%(95%CI 87.6%-98.5%)。
  • DFR 2.65在全样本中特异性为55.3%(95%CI 48.0%-62.4%),高于D-二聚体500 ng/mL(22.9%,95%CI 17.4%-29.6%)和1000 ng/mL(45.8%,95%CI 38.7%-53.1%)。
  • 各亚组结果相似。

证据类型、等级与局限

  • 证据类型为单中心回顾性病历审查(chart review),非前瞻性对照研究。
  • 作者明确指出该结果为探索性信息,需前瞻性多中心研究评估后才能考虑常规临床使用。

对床旁实践的改变

  • 该研究提示DFR切点2.65在高危VTE急诊人群中可能比D-二聚体500 ng/mL具有更高特异性,但作者明确该结果仅属探索性,需前瞻性多中心研究验证,尚不能改变当前常规排除VTE的做法。

指南或共识出处

  • 原文未提及

以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。

英文原文(摘要)· 点击展开

BACKGROUND: Diagnosis of venous thromboembolism (VTE) requires chest CT angiography for pulmonary embolism and venous ultrasound for deep vein thrombosis. To reduce imaging, guidelines recommend D-dimer levels to rule-out VTE in patients with a low pre-test probability. The most widely used D-dimer cut-off is 500 ng/mL. This cut-off has low specificity, meaning many patients without disease require imaging.

METHODS: In this retrospective chart review, we evaluated the diagnostic performance of the D-dimer/fibrinogen ratio (DFR) for identifying thromboembolism and compared it to the performance of two different D-dimer cut-offs (500 ng/mL and 1000 ng/mL) in patients who underwent a chest CT angiography or a venous ultrasound in the ED of San Raffaele Hospital, Italy, in 2017. Patients had a retrospective Wells score calculated after chart review, identifying both high-risk and low-risk pre-test probability patients for this study and low probability patients were further stratified into low-risk of deep vein thrombosis or pulmonary embolism.

RESULTS: Enrolled patients included 92 with suspected pulmonary embolism and 154 with suspected deep vein thrombosis; of whom 67 (27%) were diagnosed with VTE. The most accurate cut-off for DFR in terms of discriminative power was 2.65. In the whole sample and in low-risk patients, this cut-off had the same sensitivity values of the 500 ng/mL D-dimer cut-off (97% (95% CI: 89.8% to 99.2%)), while slightly lower sensitivity values were found for the 1000 ng/mL D-dimer cut-off (95.5% (95% CI: 87.6% to 98.5%)). Specificity was higher for the 2.65 DFR cut-off (55.3% (95% CI: 48.0% to 62.4%)) in the whole sample compared with both 500 ng/mL D-dimer cut-off (22.9% (95% CI: 17.4% to 29.6%)) and 1000 ng/mL D-dimer cut-off (45.8% (95% CI: 38.7% to 53.1%)). Similar results were found in all subgroups.

CONCLUSION: A DFR, with a cut-off of 2.65, may improve the specificity for VTE patients when compared with D-dimer alone in high-risk VTE emergency medicine populations. This is exploratory information only, needing evaluation in prospective, multicentre studies, prior to consideration for use in routine clinical work.

来源:Emerg Med J,查看原文。版权归原作者所有。

参考来源

  1. Marcianò T, Franchini S. Could a D-dimer/fibrinogen ratio have a role in ruling-out venous thromboembolism? Emerg Med J. 2021. PMID: 34493596. doi:10.1136/emermed-2020-210688

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。